← Leaderboards
Qing Miao
Medical College Of Wisconsin
$10,190,097
Attributed
$10,190,097
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,190,097 · 5
By mechanism
R01$10,190,097 · 5
Top collaborators
No co-investigators on record.
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Kirkwood A Pritchard$11,465,509
- Shane A Phillips$12,782,736
- Pin-Lan Li$28,114,267
- Ze Zheng$2,576,571
- Hiroto Miura$1,902,343
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisPathway InteractionsMediatingSignal TransductionPlayReceptorReceptor BindingCell MembraneDisabilityMissionTherapy DevelopmentKnockout MiceSignal PathwayMolecularUnited States National Institutes Of HealthPreventImpairmentLaboratoriesBaseHepaticHepatocyteMembraneHigh Fat DietLead
Grant awards (21)
Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver$559,301
R01 · FY2025 · DK · contact PI
Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance$546,459
R01 · FY2025 · DK · contact PI
Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver$599,835
R01 · FY2024 · DK · contact PI
Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance$574,937
R01 · FY2024 · DK · contact PI
Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver$629,891
R01 · FY2023 · DK · contact PI
Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance$592,536
R01 · FY2023 · DK · contact PI
Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance$585,581
R01 · FY2022 · DK · contact PI
Roles of Nogo-B receptor in maintaining the structural integrity of blood vessels$511,814
R01 · FY2021 · HL · contact PI
Role of NgBR in Hepatic Steatosis$408,222
R01 · FY2021 · DK · contact PI
Roles of Nogo-B receptor in maintaining the structural integrity of blood vessels$512,759
R01 · FY2020 · HL · contact PI
Role of NgBR in Hepatic Steatosis$419,790
R01 · FY2020 · DK · contact PI
Roles of Nogo-B receptor in maintaining the structural integrity of blood vessels$541,704
R01 · FY2019 · HL · contact PI
Role of NgBR in Hepatic Steatosis$443,064
R01 · FY2019 · DK · contact PI
Roles of Nogo-B receptor in maintaining the structural integrity of blood vessels$585,572
R01 · FY2018 · HL · contact PI
Role of NgBR in hepatic steatosis$433,636
R01 · FY2018 · DK · contact PI
Role of NgBR in hepatic steatosis$401,121
R01 · FY2017 · DK · contact PI
Role of NgBR$369,375
R01 · FY2015 · HL · contact PI
Role of NgBR$367,500
R01 · FY2014 · HL · contact PI
Role of NgBR$357,000
R01 · FY2013 · HL · contact PI
Role of NgBR$375,000
R01 · FY2012 · HL · contact PI
Role of NgBR$375,000
R01 · FY2011 · HL · contact PI